Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ)
CNY 23.75
(-0.88%)
CNY 23.75
(-0.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.76 Billion | 5.68 Billion | 3.36 Billion | 2.81 Billion | 2.07 Billion | 1.65 Billion |
| Cost of Revenue | 1.04 Billion | 2.73 Billion | 1.39 Billion | 870.74 Million | 721.01 Million | 643.76 Million |
| Gross Profit | 1.72 Billion | 2.94 Billion | 1.96 Billion | 1.94 Billion | 1.35 Billion | 1 Billion |
| Operating Expenses | 1.17 Billion | 1.52 Billion | 1.23 Billion | 1.07 Billion | 793.95 Million | 615.73 Million |
| Selling, General and Administrative Expenses | 737.35 Million | 1 Billion | 762.22 Million | 699.11 Million | 561.81 Million | 425.22 Million |
| Research and Development Expenses | 378 Million | 418.83 Million | 391.09 Million | 279.42 Million | 160.44 Million | 137.23 Million |
| Other Expenses | 60.02 Million | 100.88 Million | 82.26 Million | 92.32 Million | 71.69 Million | -2.85 Million |
| Cost and Expenses | 2.21 Billion | 4.26 Billion | 2.63 Billion | 1.94 Billion | 1.51 Billion | 1.25 Billion |
| Operating Income | 549.13 Million | 1.36 Billion | 691.89 Million | 740.09 Million | 508.78 Million | 411.99 Million |
| Interest Expense | 29.93 Million | 31.06 Million | 27.75 Million | 11.13 Million | 3.83 Million | 4.67 Million |
| Income Tax Expense | 53.33 Million | 174.5 Million | 47.9 Million | 114.12 Million | 76.01 Million | 62.55 Million |
| Earnings before Tax | 540.76 Million | 1.36 Billion | 680.48 Million | 730.93 Million | 503.11 Million | 409.14 Million |
| Net Income | 487.62 Million | 1.19 Billion | 634.43 Million | 634.17 Million | 387.46 Million | 307.74 Million |
| Earnings Per Share Basic | 1.10 | 2.71 | 1.43 | 1.44 | 0.88 | 0.71 |
| Earnings Per Share Diluted | 1.10 | 2.71 | 1.43 | 1.44 | 0.88 | 0.71 |
| Weighted Average Shares Outstanding | 443.29 Million | 441.68 Million | 443.65 Million | 441.57 Million | 441.55 Million | 434.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 443.29 Million | 441.68 Million | 443.65 Million | 441.57 Million | 441.55 Million | 434.85 Million |
| Gross Margin | 0.62 | 0.52 | 0.58 | 0.69 | 0.65 | 0.61 |
| EBIT Margin | 0.31 | 0.31 | 0.28 | 0.36 | 0.32 | 0.30 |
| Profit Margin | 0.18 | 0.21 | 0.19 | 0.23 | 0.19 | 0.19 |
| EBITDA | 859.12 Million | 1.67 Billion | 921.21 Million | 890.7 Million | 621 Million | 485.75 Million |
| Earnings Before Tax Margin | 0.20 | 0.24 | 0.21 | 0.26 | 0.25 | 0.25 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 606.11 Million | 712.02 Million | 858.05 Million | 760.49 Million | 2.76 Billion | 515.78 Million |
| Cost of Revenue | 235.97 Million | 321.8 Million | 290.14 Million | 288.87 Million | 1.03 Billion | 202.34 Million |
| Gross Profit | 370.13 Million | 390.22 Million | 567.9 Million | 471.61 Million | 1.73 Billion | 313.43 Million |
| Operating Expenses | 268.99 Million | 255.9 Million | 332.31 Million | 367 Million | 1.21 Billion | 255.71 Million |
| Selling, General and Administrative Expenses | 486.84 Million | 177.59 Million | 226.76 Million | 120.69 Million | - | 247.99 Million |
| Research and Development Expenses | 73.87 Million | 78.3 Million | 105.54 Million | 118.52 Million | - | 68.73 Million |
| Other Expenses | -291.72 Million | -1.2 Million | -669.06 Thousand | -10.87 Million | -14.15 Million | -1.91 Million |
| Cost and Expenses | 504.96 Million | 577.7 Million | 622.46 Million | 655.87 Million | 2.24 Billion | 458.06 Million |
| Operating Income | 90.88 Million | 134.32 Million | 235.59 Million | 86.36 Million | 549.13 Million | 74.55 Million |
| Interest Expense | 6.54 Million | 7.94 Million | 7.14 Million | 8.44 Million | 29.93 Million | 6.78 Million |
| Income Tax Expense | 5.98 Million | 15.87 Million | 31.16 Million | -8.46 Million | 53.33 Million | 8.02 Million |
| Earnings before Tax | 87.49 Million | 158.07 Million | 254.6 Million | 81.27 Million | 540.76 Million | 72.88 Million |
| Net Income | 80.13 Million | 137.46 Million | 218.33 Million | 87.81 Million | 487.62 Million | 65.3 Million |
| Earnings Per Share Basic | 0.17 | 0.29 | 0.47 | 0.19 | - | 0.15 |
| Earnings Per Share Diluted | 0.17 | 0.29 | 0.47 | 0.19 | - | 0.15 |
| Weighted Average Shares Outstanding | 480.99 Million | 468.5 Million | 468.41 Million | 455.12 Million | 443.29 Million | 440.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 480.99 Million | 468.5 Million | 468.41 Million | 455.12 Million | 443.29 Million | 440.7 Million |
| Gross Margin | 0.61 | 0.55 | 0.66 | 0.62 | 0.63 | 0.61 |
| EBIT Margin | 0.16 | 0.28 | 0.31 | 0.13 | - | 0.13 |
| Profit Margin | 0.13 | 0.19 | 0.25 | 0.12 | 0.18 | 0.13 |
| EBITDA | 94.03 Million | 201.94 Million | 266.34 Million | 101.91 Million | - | 64.75 Million |
| Earnings Before Tax Margin | 0.15 | 0.19 | 0.27 | 0.11 | 0.20 | 0.14 |
PIMO
DELPHIFX
010690
7719
CGKEY
SHWGF